Meta Pixel

News and Announcements

Altech Chemicals is on the path to global leadership as a supplier of the highly demanded chemical – 99.99% pure alumina

  • Published November 16, 2020 12:00AM UTC
  • Publisher Wholesale Investor
  • Categories Company Updates

“Altech Chemicals Limited (Altech/the Company) is poised to become one of the world’s leading suppliers of 99.99% (4N) high purity alumina (Al2O3) (HPA) through the construction and operation of a 4,500tpa HPA manufacturing plant at Johor, Malaysia. HPA is a high-value (US$28,000 – US$40,000 per tonne) high margin and highly demanded product, as it is the non-substitutable ingredient for the production of synthetic sapphire and is increasingly consumed in the manufacture of lithium-ion batteries.

Ignatius (Iggy) Tan, Managing Director, Altech Chemicals Ltd (ASX:ATC) 

Register Interest

Problem

  • HPA demand is growing at ~30% p.a.
  • New demand from lithium-ion battery industry (electric vehicles) and LED lighting (synthetic sapphire)
  • HPA currently produced from expensive aluminium metal feedstock
  • A 3-step energy intensive and environmentally impacting process
  • Bauxite mining, refining to alumina, then smelting to aluminium
  • Red muds and significant Co2 emissions for aluminium manufacture

Solution

  • Altech’s single step patented kaolin to HPA production process
  • Altech process certified “green” by CICERO (University of Olso, Norway)
  • ~46% less greenhouse gasses compared to conventional process
  • Lower cost of production, 40%-60% lower
  • Primary reactant in Altech’s process (hydrochloric acid) is recycled

Competitve Edge

  • A patented single step HPA production process
  • Internationally renowned partners:
    – German government owned KfW IPEX-Bank US$190m senior project finance
    – Euler Hemes – German export credit agency
    – SMS group gmbH, German construction contractor – also significant Altech shareholder
    – Deutsche Balaton/Delphi – German investment group holding up to 19.9% of Altech shares (post Entitlement Offer)
    – Melewar Group – Malaysian industrial group holder >10% of Altech
    – Mitsubishi – offtake partner
  • Stages 1 & 2 early works construction completed at the Johor HPA plant site, Malaysia under the fixed price plant construction contract.
  • First to market applying the single step HPA manufacturing process

Team Experience

Managing Director Iggy Tan and General Manager Dr. Jingyuan Liu – both experienced Chemical Engineers that have a track record of chemical plant construction, commissioning and operations. Most recently Mr Tan and Dr Lui were instrumental in the construction, commission and operations of ASX listed Galaxy Resources’ Jiangsu Lithium Carbonate plant in China, which completed in 2011.

Raise

A 2 for 5 entitlement offer to existing shareholders priced at $0.04 per new share, with one (1) free attaching option for each two (2) new shares issued (Ex $0.08, Expiry 31-12-2022).

The offer closes 7 December 2020. Any non-shareholders interested to participate should contact the Company directly ([email protected]), as new shares (and free options) may be available under a Shortfall Offer.

Ambitions

Funds from the offer will be applied to the Company’s various European initiatives including listed Green Bonds, payments for stage 2 early works construction in Malaysia, development activities associated with an anode grade HPA product and coating know-how, outstanding consideration for the acquisition of shares in Altech Advanced Materials AG and for corporate costs and working capital – further details are contained in section 5 of the Offer Prospectus.

Highlights

  • Development of a patented single step HPA production process
  • Securing US$190m of senior project debt from German Government owned KfW IPEX-Bank
  • Agreement on a fixed-price lump-sum EPC construction contract with SMS group
  • Off-take sales arrangement with Mitsubishi
  • Malaysian government tax incentive –no corporate tax for first 10 years of operations
  • Solid group of German and Malaysian shareholders and other stakeholders

Register Interest

Capital Insights
The Ferrari of Immunotherapy: Chimeric’s High-Stakes Race to Cure Cancer

In the high-stakes world of biotechnology, the most sophisticated weapon against cancer isn’t a new chemical compound but the patient’s own immune system, re-engineered with the precision of a high-performance engine. “This particular CAR T is like a Ferrari,” says Dr. Rebecca McQualter, CEO of Chimeric Therapeutics (ASX: CHM). “It’s got two big engines on […]

Capital Insights
From Algae Pioneers to a Natural Revolution: The Second Act of WRS Bioproducts

As the US FDA prepares to phase out synthetic food colors by the end of 2026, WRS Bioproducts is stepping in to solve a looming supply crisis. Led by industry pioneer Harry Rosen, the company is leveraging 40 years of industrial algae farming expertise to scale production of natural, superior-quality beta-carotene, positioning itself as a vital supplier in the rapidly shifting global market for natural ingredients.

Join over 45,000+ sophisticated investors

Join Now